Vaccination of whole CLL cells admixed with irradiated GM-CSF-secreting K562 bystander cells also promoted the expansion of IFN-γ+ leukemic-reactive T cells against CLL in patients after hematopoietic stem cell transplantation [9]. The gene discussed is IFNG; the disease is B-cell chronic lymphocytic leukemia.